October 12, 2008 – Research results indicate that optical coherence tomography (OCT) may be the best tool available to detect vulnerable plaque (VP) in coronary arteries, according to findings that will be presented at the 20th annual Transcatheter Cardiovascular Therapeutics (TCT) scientific symposium, sponsored by the Cardiovascular Research Foundation (CRF).
October 13, 2008 - GE Healthcare and Boston Scientific Corp. agreed to collaborate to improve intravascular ultrasound ...
October 13, 2008 - Boston Scientific Corp. released comprehensive data for the TAXUS ATLAS clinical program, a series of ...
Providing exceptional cardiovascular care for patients to achieve the best possible outcomes is the number one goal for ...
October 13, 2008 – Piedmont Hospital in Atlanta, GA, is installing the Aquilion ONE from Toshiba America Medical Systems ...
October 13, 2008 - Of those treated with Medtronic’s Endeavor Resolute drug-eluting stent (DES) in the RESOLUTE IDE ...
October 10, 2008 - A recent study published in the October issue of Journal of Neuroimaging showed CT angiography (CTA) ...
Cardiac positron emission tomography (PET) is growing in popularity among cardiologists because it provides the ability ...
October 10, 2008 - TeraRecon Inc. this weekend will release new innovations in its flagship Aquarius iNtuition platform ...
October 10, 2008 - Boston Scientific Corp. today said it received FDA approval to market its second-generation TAXUS Liberte Paclitaxel-Eluting Coronary Stent System and the company plans to launch the stent early next month in the U.S.
October 8, 2008 – To evaluate patient safety and quality care benefits of medical devices that share data with EMRs ...
When performing radiofrequency (RF) ablation to treat cardiac arrhythmia, medical professionals must balance the safety ...
October 9, 2008 - A report on initial clinical experiences with Prescient Medical’s vProtect Luminal Shield in patients ...
October 9, 2008 - Datascope Corp. said today it will sponsor a 300-patient, randomized clinical trial in high-risk acute ...
October 9, 2008 - Lumen Biomedical Inc. said today the FDA cleared the LBI Embolectomy System for use in the removal of ...
Change Healthcare Cardiology Hemodynamics is an integrated hemodynamic monitoring system for monitoring vital signs and ...
October 9, 2008 – Endosense this week launched the TOCCATA (TOuCh for CATheter Ablation) clinical study to evaluate the ...
October 9, 2008 - Boston Scientific Corp. yesterday said it completed enrollment in the PERSEUS trial, designed to ...
For catheterization labs performing both cardiac and vascular interventions, Philips Healthcare will highlight clinical tools like Allura 3D Coronary Angiography and StentBoost, as well as several new Allura Xper FD 20 features including a larger, tableside module with the ability to download images or runs to a USB stick.